-
Dialogue with Professor Yang Yong: Abiraterone helps prostate cancer patients "full process" benefit | Choose the power of "Ze
Time of Update: 2021-05-10
"Professor Yang Yong leads his "small" team to keep up with the international "trend" of prostate cancer treatment, master the experience of using new drugs and new treatment methods, and provide patients with better services.
-
Microflora topic|The application of intestinal flora transplantation in diseases
Time of Update: 2021-05-09
Experimental results: (1) The safety of FMT combined with anti-PD-1 agents was good, and 3 patients had a clinical response; (2) Fecal bacterial transplantation (FMT) changed the recipient’s intestinal flora, which is conducive to immunotherapy.
-
Looking back at the classics | 10 years of rapid changes, the new hypoglycemic drug GLP-1RA has traveled in China
Time of Update: 2021-05-09
45%, and it was also found that liraglutide can significantly reduce weight and the risk of hypoglycemia is extremely low, making the proportion of patients reaching the composite endpoint of HbA1c+no weight gain+no hypoglycemia better than the control group [4].
-
Quick view
Time of Update: 2021-05-09
the EVOLVE Study. J Crohns Colitis. 2021 Mar 31:jjab058. doi: 10. 1093 /ecco-jcc/jjab058. Epub ahead of print. PMID: 33786600. [2]Singh S, Heien HC, Herrin J, Dulai PS, Sangaralingham L, Shah ND
-
University students can't stop their mouths, and the risk of diabetes increases by 65
Time of Update: 2021-05-09
However, the recent research published in "Clin Nutr" shattered people's illusion that the risk of diabetes increased by 65% if college students eat more ultra-processed food!
-
Cell Stem Cell︱Qingfeng Wu's laboratory reveals the law of "cascade diversification" of neurons
Time of Update: 2021-05-09
, Cell Stem Cell (2021)) Third, the researchers found after analyzing the early neuronal developmental lineages , Hypothalamic RGCs produced two clusters of intermediate precursor cells (IPC), which were defined as Ascl1+ and Neurog2+ hypothalamic IPCs (Figure 3A-B).
-
Interpretation of Chinese Guidelines for Diabetic Nephropathy (Part 2
Time of Update: 2021-05-09
Figure 3: How the choice to control proteinuria regulates blood lipids Lowering LDL-c levels can reduce the risk of cardiovascular events in patients with DKD.
-
Stroke disease monitoring, see what the latest Chinese expert consensus says
Time of Update: 2021-05-09
Intracranial pressure monitoring is recommended for such patients (level B evidence, category IIa recommendation) .
-
The diagnosis and treatment of chronic cerebral ischemia is done in one article
Time of Update: 2021-05-09
blood flow 25～45 ml/(100g·min) )] instead of focal cerebral ischemia. Taking into account the diversity of the causes of CCH, it can be defined as a series of brain dysfunction syndromes caused by long-term vascular
-
Colorectal polyps found on physical examination, cut
Time of Update: 2021-05-09
Colonoscopy follow-up observation; [weak recommendation (agreement rate 82%), level of evidence D] (3) flat and sunken tumorous lesions even if ≤5mm should be endoscopic resection.
-
Step into the 2020 CDS guidelines, new programs, new drugs, new technologies, and diabetes treatment keep pace with the times
Time of Update: 2021-05-09
Guidelines" incorporates innovative technologies and indicators related to blood glucose monitoring to protect patients' blood glucose standards. Blood glucose monitoring is an important part of diabetes
-
Eradicate Helicobacter pylori and effectively prevent gastric cancer
Time of Update: 2021-05-09
of atrophy of the gastric mucosa, forming a vicious circle. Fresh vegetables and fruits with antioxidant effects can inhibit and block the production of carcinogenic nitroso compounds, thereby inhibiting
-
International Vision | Liver Cancer: Double-immune treatment data is updated again, liver cancer patients usher in "warm spring
Time of Update: 2021-05-09
Daniel Lin from the Sidney Kimmel Cancer Center pointed out that the results of the Phase III IMbrave150 study and the Phase I/II CheckMate-040 study mutually confirmed the efficacy and role of immune combination therapy in hepatocellular carcinoma (HCC).
-
The adverse reaction of cephalosporin antibiotics-disulfiram-like reaction, how much do you know
Time of Update: 2021-05-09
A case of disulfiram reaction caused by drinking alcohol after intravenous infusion of cefepime[J].
-
"The Lancet": There are only 4 steps from "high uric acid" to "tophi
Time of Update: 2021-05-09
or renal impairment [estimated glomerular filtration rate (eGFR) <90 ml/min], high blood pressure, impaired glucose tolerance or diabetes, dyslipidemia, obesity, coronary heart disease, stroke, cardiac insufficiency, start immediately Drug treatment
-
Nat Neurosci︱GWAS analysis reveals a new gene (new protein) that has a clear causal relationship with depression
Time of Update: 2021-05-09
, HIBADH, CACNA2D2, SLC25A12, CDH13 these 9 genes have good reproducibility (reproducibility) of PWAS results (Table 2); human dorsolateral The single-cell RNA sequencing data of the prefrontal cortex showed that five genes were highly expressed
-
Lupus patients have kidney and blood system involvement, but it is not because of lupus
Time of Update: 2021-05-09
, and inability to lie on their backs, and further improve BNP and cardiac color Doppler ultrasound. BNP: 3148pg/ml, color Doppler ultrasound showed enlarged left atrium, severe mitral regurgitation, moderate tricuspid
-
CSCO Colorectal Cancer Diagnosis and Treatment Guidelines Update 2021, one article is cleared
Time of Update: 2021-05-09
and quickly, and to create conditions for surgery. A small sample of research shows that FOLFOXIRI + cetuximab can significantly improve the objective response rate (ORR) of potentially resectable patients, so it is regarded as a level III
-
A number of machinery companies announced their performance: Johnson & Johnson, Abbott, GE
Time of Update: 2021-05-09
847 billion, and medical business revenue was US$4.
847 billion, and medical business revenue was US$4.
847 billion, and medical business revenue was US$4.
-
A+T regimen can change the treatment practice of patients with unresectable liver cancer in China; the first-line treatment of esophageal squamous cell carcinoma with teriprizumab in Phase III study is successful
Time of Update: 2021-05-09
information" in the tumor circle! (If you need the original text of the literature, you can add to the editor WeChat yxj_oncology to obtain) Key points remind Liver Cancer: A+T regimen can change the treatment practice of Chinese patients
